Cargando…

EXACT: rivastigmine improves the high prevalence of attention deficits and mood and behaviour symptoms in Alzheimer's disease*

The objective of this study was to investigate the impact of rivastigmine therapy on attention, apathy, anxiety and agitation in patients with mild-to-moderate Alzheimer's disease (AD) in a real-world clinical setting. Patients with mild-to-moderate AD were enrolled in the study by physicians a...

Descripción completa

Detalles Bibliográficos
Autores principales: Gauthier, S, Juby, A, Rehel, B, Schecter, R
Formato: Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2007
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1974793/
https://www.ncbi.nlm.nih.gov/pubmed/17504350
http://dx.doi.org/10.1111/j.1742-1241.2007.01387.x